Further survival analyses of triple-negative breast cancer datasets showed that high TrkA activation and high co-activation, but not STAT3 activation, were associated with shortened time to develop brain metastasis (Figure 6A). Here, NTRK1 is linked to triple-negative breast carcinoma.